Banque Pictet & Cie Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Australia ETF
EWA
|
+$20.1M |
| 2 |
VanEck Oil Services ETF
OIH
|
+$18M |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$17.3M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$16.1M |
| 5 |
SPDR Gold Trust
GLD
|
+$13.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$27.9M |
| 2 |
Apple
AAPL
|
+$22.9M |
| 3 |
Honeywell
HON
|
+$22.4M |
| 4 |
US Bancorp
USB
|
+$16.7M |
| 5 |
Costco
COST
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 14.17% |
| 2 | Consumer Discretionary | 13.68% |
| 3 | Healthcare | 12.28% |
| 4 | Consumer Staples | 9.49% |
| 5 | Technology | 8.47% |
Similar funds
Banque Pictet & Cie's Q1 2017 Portfolio in Review
As of Q1 2017, Banque Pictet & Cie held 371 positions worth $4.04B, up 4.1% from $3.88B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Banque Pictet & Cie withdrew a net $137M in Q1 2017, closing 34 positions and reducing 116 holdings. Its most notable exit was iShares MSCI Canada ETF, an estimated $13.5M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Banque Pictet & Cie opened a new position in Teva Pharmaceuticals worth $15.5M.
- Banque Pictet & Cie's largest Q1 2017 buy was Teva Pharmaceuticals: 472,383 shares worth $15.5M.
- Banque Pictet & Cie added most to iShares MSCI Australia ETF in Q1 2017, an estimated $20.1M increase.
- Banque Pictet & Cie's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $27.9M.
- Banque Pictet & Cie fully exited iShares MSCI Canada ETF in Q1 2017, selling an estimated $13.5M.
- Banque Pictet & Cie's ten largest holdings make up 32% of its $4.04B portfolio in Q1 2017.
- Banque Pictet & Cie opened 50 new positions and closed 34 in Q1 2017.
- Banque Pictet & Cie's portfolio value rose 4.1% quarter-over-quarter to $4.04B.
Based on Banque Pictet & Cie's 13F filing for Q1 2017, filed 12 May 2017.